$ATRX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Adhera Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Adhera Therapeutics, Inc.. Get notifications about new insider transactions in Adhera Therapeutics, Inc. for free.
Page: < prev 1 2 3 4 5 6 7 8 ... 9 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 26 2007 | MRNA | Marina Biotech, In ... | QUAY STEVEN C | Chairman, President ... | Sell | S | 13.51 | 2,000 | 27,021 | 474,692 | 476.7 K to 474.7 K (-0.42 %) |
| Jan 24 2007 | MRNA | Marina Biotech, In ... | JOHNSON PAUL H | Sr VP of R&D, CSO | Payment of Exercise | F | 13.31 | 352 | 4,685 | 10,052 | 10.4 K to 10.1 K (-3.38 %) |
| Jan 24 2007 | MRNA | Marina Biotech, In ... | BRANDT GORDON | Exec VP of Science ... | Payment of Exercise | F | 13.31 | 660 | 8,785 | 11,165 | 11.8 K to 11.2 K (-5.58 %) |
| Jan 05 2007 | MRNA | Marina Biotech, In ... | Ranker Philip C | Chief Financial Off ... | Sell | S | 14.58 | 2,206 | 32,164 | 35,894 | 38.1 K to 35.9 K (-5.79 %) |
| Jan 05 2007 | MRNA | Marina Biotech, In ... | BRANDT GORDON | Exec VP of Science ... | Option Exercise | X | 8.89 | 5,000 | 44,450 | 85,000 | |
| Jan 05 2007 | MRNA | Marina Biotech, In ... | BRANDT GORDON | Exec VP of Science ... | Sell | S | 14.69 | 5,000 | 73,469 | 11,825 | 16.8 K to 11.8 K (-29.72 %) |
| Jan 05 2007 | MRNA | Marina Biotech, In ... | BRANDT GORDON | Exec VP of Science ... | Buy | M | 8.89 | 5,000 | 44,450 | 16,825 | 11.8 K to 16.8 K (+42.28 %) |
| Jan 04 2007 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 15.38 | 100 | 1,538 | 332,287 | 332.4 K to 332.3 K (-0.03 %) |
| Jan 04 2007 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 15.06 | 100 | 1,506 | 332,387 | 332.5 K to 332.4 K (-0.03 %) |
| Jan 04 2007 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 15.00 | 200 | 3,000 | 332,487 | 332.7 K to 332.5 K (-0.06 %) |
| Jan 04 2007 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 14.95 | 100 | 1,495 | 332,687 | 332.8 K to 332.7 K (-0.03 %) |
| Jan 04 2007 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 14.80 | 100 | 1,480 | 332,787 | 332.9 K to 332.8 K (-0.03 %) |
| Jan 04 2007 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 14.71 | 100 | 1,471 | 332,887 | 333 K to 332.9 K (-0.03 %) |
| Jan 04 2007 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 14.66 | 100 | 1,466 | 332,987 | 333.1 K to 333 K (-0.03 %) |
| Jan 04 2007 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 14.63 | 200 | 2,926 | 333,087 | 333.3 K to 333.1 K (-0.06 %) |
| Dec 22 2006 | MRNA | Marina Biotech, In ... | BRANDT GORDON | Exec VP of Science ... | Sell | S | 15.67 | 675 | 10,577 | 11,825 | 12.5 K to 11.8 K (-5.40 %) |
| Dec 12 2006 | MRNA | Marina Biotech, In ... | Stanewick Gerald T | Director | Buy | P | 15.67 | 700 | 10,971 | 101,612 | 100.9 K to 101.6 K (+0.69 %) |
| Dec 12 2006 | MRNA | Marina Biotech, In ... | Stanewick Gerald T | Director | Buy | P | 15.67 | 290 | 4,545 | 59,000 | 58.7 K to 59 K (+0.49 %) |
| Dec 12 2006 | MRNA | Marina Biotech, In ... | Stanewick Gerald T | Director | Buy | P | 15.67 | 433 | 6,786 | 58,710 | 58.3 K to 58.7 K (+0.74 %) |
| Dec 12 2006 | MRNA | Marina Biotech, In ... | Stanewick Gerald T | Director | Buy | P | 15.80 | 777 | 12,277 | 58,277 | 57.5 K to 58.3 K (+1.35 %) |
| Dec 01 2006 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 18.60 | 300 | 5,580 | 333,287 | 333.6 K to 333.3 K (-0.09 %) |
| Dec 01 2006 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 18.51 | 213 | 3,943 | 333,587 | 333.8 K to 333.6 K (-0.06 %) |
| Dec 01 2006 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 18.50 | 387 | 7,160 | 333,800 | 334.2 K to 333.8 K (-0.12 %) |
| Dec 01 2006 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 18.44 | 200 | 3,688 | 334,187 | 334.4 K to 334.2 K (-0.06 %) |
| Dec 01 2006 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 18.40 | 100 | 1,840 | 334,387 | 334.5 K to 334.4 K (-0.03 %) |
| Dec 01 2006 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 18.31 | 200 | 3,662 | 334,487 | 334.7 K to 334.5 K (-0.06 %) |
| Dec 01 2006 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 18.30 | 400 | 7,320 | 334,687 | 335.1 K to 334.7 K (-0.12 %) |
| Dec 01 2006 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 18.28 | 400 | 7,312 | 335,087 | 335.5 K to 335.1 K (-0.12 %) |
| Dec 01 2006 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 18.23 | 200 | 3,646 | 335,487 | 335.7 K to 335.5 K (-0.06 %) |
| Dec 01 2006 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 18.22 | 400 | 7,288 | 335,687 | 336.1 K to 335.7 K (-0.12 %) |
| Dec 01 2006 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 18.21 | 200 | 3,642 | 336,087 | 336.3 K to 336.1 K (-0.06 %) |
| Dec 07 2006 | MRNA | Marina Biotech, In ... | BRANDT GORDON | Exec VP of Science ... | Option Exercise | X | 10.99 | 5,000 | 54,950 | 90,000 | |
| Dec 07 2006 | MRNA | Marina Biotech, In ... | BRANDT GORDON | Exec VP of Science ... | Sell | S | 16.18 | 5,000 | 80,913 | 12,500 | 17.5 K to 12.5 K (-28.57 %) |
| Dec 07 2006 | MRNA | Marina Biotech, In ... | BRANDT GORDON | Exec VP of Science ... | Buy | M | 10.99 | 5,000 | 54,950 | 17,500 | 12.5 K to 17.5 K (+40.00 %) |
| Nov 03 2006 | MRNA | Marina Biotech, In ... | BRANDT GORDON | Exec VP of Science ... | Option Exercise | X | 10.99 | 5,000 | 54,950 | 95,000 | |
| Nov 03 2006 | MRNA | Marina Biotech, In ... | BRANDT GORDON | Exec VP of Science ... | Sell | S | 16.45 | 5,000 | 82,263 | 12,500 | 17.5 K to 12.5 K (-28.57 %) |
| Nov 03 2006 | MRNA | Marina Biotech, In ... | BRANDT GORDON | Exec VP of Science ... | Buy | M | 10.99 | 5,000 | 54,950 | 17,500 | 12.5 K to 17.5 K (+40.00 %) |
| Nov 17 2006 | MRNA | Marina Biotech, In ... | QUAY STEVEN C | Chairman, President ... | Sell | S | 19.61 | 620 | 12,158 | 476,692 | 477.3 K to 476.7 K (-0.13 %) |
| Nov 17 2006 | MRNA | Marina Biotech, In ... | QUAY STEVEN C | Chairman, President ... | Sell | S | 19.65 | 1,000 | 19,650 | 477,312 | 478.3 K to 477.3 K (-0.21 %) |
| Nov 17 2006 | MRNA | Marina Biotech, In ... | QUAY STEVEN C | Chairman, President ... | Sell | S | 19.43 | 2,000 | 38,860 | 478,312 | 480.3 K to 478.3 K (-0.42 %) |
| Nov 02 2006 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 17.80 | 400 | 7,120 | 336,287 | 336.7 K to 336.3 K (-0.12 %) |
| Nov 02 2006 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 17.75 | 500 | 8,875 | 336,687 | 337.2 K to 336.7 K (-0.15 %) |
| Nov 02 2006 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 17.65 | 200 | 3,530 | 337,187 | 337.4 K to 337.2 K (-0.06 %) |
| Nov 02 2006 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 17.61 | 94 | 1,655 | 337,387 | 337.5 K to 337.4 K (-0.03 %) |
| Nov 02 2006 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 17.59 | 100 | 1,759 | 337,481 | 337.6 K to 337.5 K (-0.03 %) |
| Nov 02 2006 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 17.58 | 100 | 1,758 | 337,581 | 337.7 K to 337.6 K (-0.03 %) |
| Nov 02 2006 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 17.57 | 300 | 5,271 | 337,681 | 338 K to 337.7 K (-0.09 %) |
| Nov 02 2006 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 17.54 | 500 | 8,770 | 337,981 | 338.5 K to 338 K (-0.15 %) |
| Nov 02 2006 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 17.53 | 100 | 1,753 | 338,481 | 338.6 K to 338.5 K (-0.03 %) |
| Nov 02 2006 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 17.52 | 306 | 5,361 | 338,581 | 338.9 K to 338.6 K (-0.09 %) |
| Nov 02 2006 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 17.50 | 300 | 5,250 | 338,887 | 339.2 K to 338.9 K (-0.09 %) |
| Nov 02 2006 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 17.45 | 100 | 1,745 | 339,187 | 339.3 K to 339.2 K (-0.03 %) |
| Oct 31 2006 | MRNA | Marina Biotech, In ... | Stanewick Gerald T | Director | Gift | G | 0.00 | 1,300 | 0 | 100,912 | 102.2 K to 100.9 K (-1.27 %) |
| Oct 10 2006 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 16.00 | 2,000 | 32,000 | 339,287 | 341.3 K to 339.3 K (-0.59 %) |
| Oct 10 2006 | MRNA | Marina Biotech, In ... | Stanewick Gerald T | Director | Buy | P | 15.75 | 3,000 | 47,250 | 102,212 | 99.2 K to 102.2 K (+3.02 %) |
| Oct 10 2006 | MRNA | Marina Biotech, In ... | QUAY STEVEN C | Chairman, President ... | Sell | S | 15.63 | 175 | 2,735 | 480,312 | 480.5 K to 480.3 K (-0.04 %) |
| Oct 10 2006 | MRNA | Marina Biotech, In ... | QUAY STEVEN C | Chairman, President ... | Sell | S | 15.62 | 2,000 | 31,231 | 480,487 | 482.5 K to 480.5 K (-0.41 %) |
| Oct 10 2006 | MRNA | Marina Biotech, In ... | QUAY STEVEN C | Chairman, President ... | Sell | S | 15.60 | 3,000 | 46,800 | 482,487 | 485.5 K to 482.5 K (-0.62 %) |
| Oct 06 2006 | MRNA | Marina Biotech, In ... | JOHNSON PAUL H | Sr VP of R&D, CSO | Sell | S | 15.54 | 661 | 10,272 | 10,404 | 11.1 K to 10.4 K (-5.97 %) |
| Oct 05 2006 | MRNA | Marina Biotech, In ... | BRANDT GORDON | Exec VP of Science ... | Option Exercise | X | 10.99 | 5,000 | 54,950 | 100,000 | |
| Oct 05 2006 | MRNA | Marina Biotech, In ... | BRANDT GORDON | Exec VP of Science ... | Sell | S | 15.14 | 5,000 | 75,709 | 12,500 | 17.5 K to 12.5 K (-28.57 %) |
| Oct 05 2006 | MRNA | Marina Biotech, In ... | BRANDT GORDON | Exec VP of Science ... | Buy | M | 10.99 | 5,000 | 54,950 | 17,500 | 12.5 K to 17.5 K (+40.00 %) |
| Oct 03 2006 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 15.43 | 200 | 3,086 | 341,287 | 341.5 K to 341.3 K (-0.06 %) |
| Oct 03 2006 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 15.37 | 100 | 1,537 | 341,487 | 341.6 K to 341.5 K (-0.03 %) |
| Oct 03 2006 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 15.35 | 100 | 1,535 | 341,587 | 341.7 K to 341.6 K (-0.03 %) |
| Oct 03 2006 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 15.34 | 200 | 3,068 | 341,687 | 341.9 K to 341.7 K (-0.06 %) |
| Oct 03 2006 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 15.31 | 100 | 1,531 | 341,887 | 342 K to 341.9 K (-0.03 %) |
| Oct 03 2006 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 15.30 | 100 | 1,530 | 341,987 | 342.1 K to 342 K (-0.03 %) |
| Oct 03 2006 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 15.25 | 200 | 3,050 | 342,087 | 342.3 K to 342.1 K (-0.06 %) |
| Sep 07 2006 | MRNA | Marina Biotech, In ... | BRANDT GORDON | Exec VP of Science ... | Option Exercise | X | 10.99 | 5,000 | 54,950 | 105,000 | |
| Sep 07 2006 | MRNA | Marina Biotech, In ... | BRANDT GORDON | Exec VP of Science ... | Sell | S | 15.10 | 5,000 | 75,521 | 12,500 | 17.5 K to 12.5 K (-28.57 %) |
| Sep 07 2006 | MRNA | Marina Biotech, In ... | BRANDT GORDON | Exec VP of Science ... | Buy | M | 10.99 | 5,000 | 54,950 | 17,500 | 12.5 K to 17.5 K (+40.00 %) |
| Sep 05 2006 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 15.28 | 100 | 1,528 | 342,287 | 342.4 K to 342.3 K (-0.03 %) |
| Sep 05 2006 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 15.15 | 300 | 4,545 | 342,387 | 342.7 K to 342.4 K (-0.09 %) |
| Sep 05 2006 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 15.10 | 300 | 4,530 | 342,687 | 343 K to 342.7 K (-0.09 %) |
| Sep 05 2006 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 15.08 | 200 | 3,016 | 342,987 | 343.2 K to 343 K (-0.06 %) |
| Sep 05 2006 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 15.01 | 100 | 1,501 | 343,187 | 343.3 K to 343.2 K (-0.03 %) |
| Aug 15 2006 | MRNA | Marina Biotech, In ... | YORK BRUCE R | Sell | S | 14.23 | 882 | 12,551 | 15,960 | 16.8 K to 16 K (-5.24 %) | |
| Aug 04 2006 | MRNA | Marina Biotech, In ... | BRANDT GORDON | Exec VP of Science ... | Option Exercise | X | 10.99 | 833 | 9,155 | 110,000 | |
| Aug 04 2006 | MRNA | Marina Biotech, In ... | BRANDT GORDON | Exec VP of Science ... | Option Exercise | M | 10.39 | 2,500 | 25,975 | 110,833 | |
| Aug 04 2006 | MRNA | Marina Biotech, In ... | BRANDT GORDON | Exec VP of Science ... | Option Exercise | X | 8.89 | 1,667 | 14,820 | 113,333 | |
| Aug 04 2006 | MRNA | Marina Biotech, In ... | BRANDT GORDON | Exec VP of Science ... | Sell | S | 13.85 | 5,000 | 69,263 | 12,500 | 17.5 K to 12.5 K (-28.57 %) |
| Aug 04 2006 | MRNA | Marina Biotech, In ... | BRANDT GORDON | Exec VP of Science ... | Buy | M | 10.99 | 833 | 9,155 | 17,500 | 16.7 K to 17.5 K (+5.00 %) |
| Aug 04 2006 | MRNA | Marina Biotech, In ... | BRANDT GORDON | Exec VP of Science ... | Buy | M | 10.39 | 2,500 | 25,975 | 16,667 | 14.2 K to 16.7 K (+17.65 %) |
| Aug 04 2006 | MRNA | Marina Biotech, In ... | BRANDT GORDON | Exec VP of Science ... | Buy | M | 8.89 | 1,667 | 14,820 | 14,167 | 12.5 K to 14.2 K (+13.34 %) |
| Aug 08 2006 | MRNA | Marina Biotech, In ... | QUAY STEVEN C | Chairman, President ... | Sell | S | 14.03 | 1,820 | 25,534 | 485,487 | 487.3 K to 485.5 K (-0.37 %) |
| Aug 08 2006 | MRNA | Marina Biotech, In ... | QUAY STEVEN C | Chairman, President ... | Sell | S | 13.83 | 2,000 | 27,660 | 487,307 | 489.3 K to 487.3 K (-0.41 %) |
| Aug 08 2006 | MRNA | Marina Biotech, In ... | QUAY STEVEN C | Chairman, President ... | Sell | S | 13.77 | 2,000 | 27,545 | 489,307 | 491.3 K to 489.3 K (-0.41 %) |
| Aug 04 2006 | MRNA | Marina Biotech, In ... | Duffy Timothy M | Exec. VP of Busines ... | Sell | S | 15.58 | 200 | 3,116 | 33,392 | 33.6 K to 33.4 K (-0.60 %) |
| Aug 02 2006 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 13.60 | 86 | 1,170 | 343,287 | 343.4 K to 343.3 K (-0.03 %) |
| Aug 02 2006 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 13.49 | 100 | 1,349 | 343,373 | 343.5 K to 343.4 K (-0.03 %) |
| Aug 02 2006 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 13.47 | 200 | 2,694 | 343,473 | 343.7 K to 343.5 K (-0.06 %) |
| Aug 02 2006 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 13.35 | 200 | 2,670 | 343,673 | 343.9 K to 343.7 K (-0.06 %) |
| Aug 02 2006 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 13.25 | 314 | 4,161 | 343,873 | 344.2 K to 343.9 K (-0.09 %) |
| Aug 02 2006 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 13.10 | 100 | 1,310 | 344,187 | 344.3 K to 344.2 K (-0.03 %) |
| Jul 21 2006 | MRNA | Marina Biotech, In ... | QUAY STEVEN C | Chairman, President ... | Payment of Exercise | F | 12.22 | 11,103 | 135,679 | 491,307 | 502.4 K to 491.3 K (-2.21 %) |
| Jul 17 2006 | MRNA | Marina Biotech, In ... | YORK BRUCE R | Grant | A | 0.00 | 3,093 | 0 | 16,842 | 13.7 K to 16.8 K (+22.50 %) | |
| Jul 06 2006 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 16.00 | 500 | 8,000 | 344,287 | 344.8 K to 344.3 K (-0.15 %) |
| Jul 06 2006 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 15.85 | 100 | 1,585 | 344,787 | 344.9 K to 344.8 K (-0.03 %) |
| Jul 06 2006 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 15.75 | 100 | 1,575 | 344,887 | 345 K to 344.9 K (-0.03 %) |
| Jul 06 2006 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 15.50 | 100 | 1,550 | 344,987 | 345.1 K to 345 K (-0.03 %) |
| Jul 06 2006 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 15.47 | 100 | 1,547 | 345,087 | 345.2 K to 345.1 K (-0.03 %) |
| Jul 06 2006 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 15.44 | 100 | 1,544 | 345,187 | 345.3 K to 345.2 K (-0.03 %) |
| Jul 06 2006 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 15.41 | 100 | 1,541 | 345,287 | 345.4 K to 345.3 K (-0.03 %) |
| Jul 06 2006 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 15.30 | 300 | 4,590 | 345,387 | 345.7 K to 345.4 K (-0.09 %) |
| Jul 06 2006 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 15.27 | 100 | 1,527 | 345,687 | 345.8 K to 345.7 K (-0.03 %) |
| Jul 06 2006 | MRNA | Marina Biotech, In ... | BRANDT GORDON | Exec VP of Science ... | Option Exercise | X | 8.89 | 5,000 | 44,450 | 115,000 | |
| Jul 06 2006 | MRNA | Marina Biotech, In ... | BRANDT GORDON | Exec VP of Science ... | Sell | S | 15.43 | 5,000 | 77,126 | 12,500 | 17.5 K to 12.5 K (-28.57 %) |
| Jul 06 2006 | MRNA | Marina Biotech, In ... | BRANDT GORDON | Exec VP of Science ... | Buy | M | 8.89 | 5,000 | 44,450 | 17,500 | 12.5 K to 17.5 K (+40.00 %) |
| Jun 28 2006 | MRNA | Marina Biotech, In ... | Duffy Timothy M | Exec. VP of Busines ... | Sell | S | 14.81 | 1,460 | 21,623 | 33,592 | 35.1 K to 33.6 K (-4.17 %) |
| Jun 15 2006 | MRNA | Marina Biotech, In ... | QUAY STEVEN C | Chairman, President ... | Sell | S | 14.73 | 1,540 | 22,689 | 502,410 | 504 K to 502.4 K (-0.31 %) |
| Jun 15 2006 | MRNA | Marina Biotech, In ... | QUAY STEVEN C | Chairman, President ... | Sell | S | 14.67 | 2,000 | 29,340 | 503,950 | 506 K to 504 K (-0.40 %) |
| Jun 15 2006 | MRNA | Marina Biotech, In ... | QUAY STEVEN C | Chairman, President ... | Sell | S | 14.34 | 2,000 | 28,680 | 505,950 | 508 K to 506 K (-0.39 %) |
| Jun 15 2006 | MRNA | Marina Biotech, In ... | MICHELSON LESLIE D | Director | Option Exercise | A | 13.36 | 9,500 | 126,920 | 30,500 | |
| Jun 15 2006 | MRNA | Marina Biotech, In ... | MICHELSON LESLIE D | Director | Grant | A | 0.00 | 6,970 | 0 | 43,970 | 37 K to 44 K (+18.84 %) |
| Jun 15 2006 | MRNA | Marina Biotech, In ... | THAW BRUCE R/FA | Director | Option Exercise | A | 13.36 | 10,000 | 133,600 | 96,000 | |
| Jun 15 2006 | MRNA | Marina Biotech, In ... | THAW BRUCE R/FA | Director | Grant | A | 0.00 | 5,000 | 0 | 109,041 | 104 K to 109 K (+4.81 %) |
| Jun 15 2006 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Option Exercise | A | 13.36 | 9,500 | 126,920 | 42,000 | |
| Jun 15 2006 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Grant | A | 0.00 | 4,500 | 0 | 345,787 | 341.3 K to 345.8 K (+1.32 %) |
| Jun 15 2006 | MRNA | Marina Biotech, In ... | Stanewick Gerald T | Director | Option Exercise | A | 13.36 | 4,000 | 53,440 | 22,000 | |
| Jun 15 2006 | MRNA | Marina Biotech, In ... | Stanewick Gerald T | Director | Grant | A | 0.00 | 2,000 | 0 | 99,212 | 97.2 K to 99.2 K (+2.06 %) |
| Jun 15 2006 | MRNA | Marina Biotech, In ... | POLLOCK JOHN V | Director | Option Exercise | A | 13.36 | 10,000 | 133,600 | 72,500 | |
| Jun 15 2006 | MRNA | Marina Biotech, In ... | POLLOCK JOHN V | Director | Grant | A | 0.00 | 5,000 | 0 | 25,833 | 20.8 K to 25.8 K (+24.00 %) |
| Jun 15 2006 | MRNA | Marina Biotech, In ... | HOLUBIAK MYRON Z | Director | Option Exercise | A | 13.36 | 9,500 | 126,920 | 27,500 | |
| Jun 15 2006 | MRNA | Marina Biotech, In ... | HOLUBIAK MYRON Z | Director | Grant | A | 0.00 | 5,735 | 0 | 23,735 | 18 K to 23.7 K (+31.86 %) |
| Jun 15 2006 | MRNA | Marina Biotech, In ... | FERRIER IAN R | Director | Option Exercise | A | 13.36 | 4,000 | 53,440 | 20,000 | |
| Jun 15 2006 | MRNA | Marina Biotech, In ... | FERRIER IAN R | Director | Grant | A | 0.00 | 3,235 | 0 | 9,235 | 6 K to 9.2 K (+53.92 %) |
| Jun 15 2006 | MRNA | Marina Biotech, In ... | CROSS ALEXANDER D | Director | Option Exercise | A | 13.36 | 10,000 | 133,600 | 26,500 | |
| Jun 15 2006 | MRNA | Marina Biotech, In ... | CROSS ALEXANDER D | Director | Grant | A | 0.00 | 5,000 | 0 | 22,500 | 17.5 K to 22.5 K (+28.57 %) |
| Jun 15 2006 | MRNA | Marina Biotech, In ... | BEESE J CARTER JR | Director | Option Exercise | A | 13.36 | 10,000 | 133,600 | 72,500 | |
| Jun 15 2006 | MRNA | Marina Biotech, In ... | BEESE J CARTER JR | Director | Grant | A | 0.00 | 5,000 | 0 | 12,500 | 7.5 K to 12.5 K (+66.67 %) |
| Jun 15 2006 | MRNA | Marina Biotech, In ... | BAYH SUSAN B | Director | Option Exercise | A | 13.36 | 8,000 | 106,880 | 23,000 | |
| Jun 15 2006 | MRNA | Marina Biotech, In ... | BAYH SUSAN B | Director | Grant | A | 0.00 | 5,235 | 0 | 20,235 | 15 K to 20.2 K (+34.90 %) |
| Jun 09 2006 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Option Exercise | X | 8.25 | 2,000 | 16,500 | 32,500 | |
| Jun 09 2006 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 13.71 | 100 | 1,371 | 341,287 | 341.4 K to 341.3 K (-0.03 %) |
| Jun 09 2006 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 13.70 | 400 | 5,480 | 341,387 | 341.8 K to 341.4 K (-0.12 %) |
| Jun 09 2006 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 13.67 | 500 | 6,835 | 341,787 | 342.3 K to 341.8 K (-0.15 %) |
| Jun 09 2006 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 13.64 | 1,000 | 13,640 | 342,287 | 343.3 K to 342.3 K (-0.29 %) |
| Jun 09 2006 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Buy | M | 8.25 | 2,000 | 16,500 | 343,287 | 341.3 K to 343.3 K (+0.59 %) |
| Jun 07 2006 | MRNA | Marina Biotech, In ... | THAW BRUCE R/FA | Director | Option Exercise | X | 8.25 | 10,000 | 82,500 | 86,000 | |
| Jun 07 2006 | MRNA | Marina Biotech, In ... | THAW BRUCE R/FA | Director | Sell | S | 14.00 | 10,000 | 140,000 | 104,041 | 114 K to 104 K (-8.77 %) |
| Jun 07 2006 | MRNA | Marina Biotech, In ... | THAW BRUCE R/FA | Director | Buy | M | 8.25 | 10,000 | 82,500 | 114,041 | 104 K to 114 K (+9.61 %) |
| Jun 07 2006 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Option Exercise | X | 8.25 | 8,000 | 66,000 | 34,500 | |
| Jun 07 2006 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 14.40 | 570 | 8,208 | 341,287 | 341.9 K to 341.3 K (-0.17 %) |
| Jun 07 2006 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 14.27 | 100 | 1,427 | 341,857 | 342 K to 341.9 K (-0.03 %) |
| Jun 07 2006 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 14.25 | 330 | 4,703 | 341,957 | 342.3 K to 342 K (-0.10 %) |
| Jun 07 2006 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 13.91 | 300 | 4,173 | 342,287 | 342.6 K to 342.3 K (-0.09 %) |
| Jun 07 2006 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 13.82 | 400 | 5,528 | 342,587 | 343 K to 342.6 K (-0.12 %) |
| Jun 07 2006 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 13.81 | 600 | 8,286 | 342,987 | 343.6 K to 343 K (-0.17 %) |
| Jun 07 2006 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 13.78 | 559 | 7,703 | 343,587 | 344.1 K to 343.6 K (-0.16 %) |